Shares of Moderna (NASDAQ: MRNA) jumped 6.3% higher as of the market close on Tuesday. The solid gain came after the company announced that the European Commission (EC) has agreed to buy an additional 150 million doses of its COVID-19 vaccine, bringing the total number of doses ordered by the EC to 460 million. Moderna announced an even bigger purchase last week with the U.S. government signing an agreement to buy 200 million additional doses of the company's COVID-19 vaccine.
Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting